These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20732643)

  • 1. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Optimising the strategy of care in early rheumatoid arthritis.
    Dale J; Porter D
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):443-55. PubMed ID: 20732643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the use of conventional disease-modifying antirheumatic drugs in the management of rheumatoid arthritis.
    Feely MG; O'Dell JR
    Curr Opin Rheumatol; 2010 May; 22(3):316-20. PubMed ID: 20190639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy: concepts of pathogenesis and emerging treatments. Challenges in clinical trial design in inflammatory arthritis.
    O'Dell JR
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):457-61. PubMed ID: 20732644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed treatment with tumor necrosis factor inhibitors in incomplete responders to synthetic disease-modifying anti-rheumatic drugs shows an excellent effect in patients with very early rheumatoid arthritis with poor prognosis factors.
    Kita J; Tamai M; Arima K; Nakashima Y; Suzuki T; Kawashiri SY; Okada A; Koga T; Yamasaki S; Nakamura H; Origuchi T; Aramaki T; Nakashima M; Fujikawa K; Tsukada T; Ida H; Aoyagi K; Uetani M; Eguchi K; Kawakami A
    Mod Rheumatol; 2012 Apr; 22(2):195-201. PubMed ID: 21898075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The anti-tumor necrosis factor agents are a major advance in the treatment of rheumatoid arthritis.
    Haraoui B
    J Rheumatol Suppl; 2005 Jan; 72():46-7. PubMed ID: 15660467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic options for rheumatoid arthritis.
    Feely MG; Erickson A; O'Dell JR
    Expert Opin Pharmacother; 2009 Sep; 10(13):2095-106. PubMed ID: 19606939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of rheumatoid arthritis: the 2012 perspective.
    Yamanaka H; Seto Y; Tanaka E; Furuya T; Nakajima A; Ikari K; Taniguchi A; Momohara S
    Mod Rheumatol; 2013 Jan; 23(1):1-7. PubMed ID: 22772460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression in early rheumatoid arthritis.
    Combe B
    Best Pract Res Clin Rheumatol; 2009 Feb; 23(1):59-69. PubMed ID: 19233046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Chen YF; Jobanputra P; Barton P; Jowett S; Bryan S; Clark W; Fry-Smith A; Burls A
    Health Technol Assess; 2006 Nov; 10(42):iii-iv, xi-xiii, 1-229. PubMed ID: 17049139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
    Hetland ML; Stengaard-Pedersen K; Junker P; Østergaard M; Ejbjerg BJ; Jacobsen S; Lottenburger T; Hansen I; Tarp U; Andersen LS; Svendsen A; Pedersen JK; Lauridsen UB; Ellingsen T; Lindegaard H; Pødenphant J; Vestergaard A; Jurik AG; Hørslev-Petersen K;
    Ann Rheum Dis; 2010 Oct; 69(10):1789-95. PubMed ID: 20444751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.
    Goekoop-Ruiterman YP; de Vries-Bouwstra JK; Allaart CF; van Zeben D; Kerstens PJ; Hazes JM; Zwinderman AH; Ronday HK; Han KH; Westedt ML; Gerards AH; van Groenendael JH; Lems WF; van Krugten MV; Breedveld FC; Dijkmans BA
    Arthritis Rheum; 2005 Nov; 52(11):3381-90. PubMed ID: 16258899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remission in rheumatoid arthritis: wishful thinking or clinical reality?
    Sesin CA; Bingham CO
    Semin Arthritis Rheum; 2005 Dec; 35(3):185-96. PubMed ID: 16325659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial.
    Martin NH; Ibrahim F; Tom B; Galloway J; Wailoo A; Tosh J; Lempp H; Prothero L; Georgopoulou S; Sturt J; Scott DL;
    Trials; 2017 Dec; 18(1):591. PubMed ID: 29221496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early rheumatoid arthritis: strategies for prevention and management.
    Combe B
    Best Pract Res Clin Rheumatol; 2007 Feb; 21(1):27-42. PubMed ID: 17350542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic strategies in early rheumatoid arthritis.
    Smolen JS; Aletaha D; Machold KP
    Best Pract Res Clin Rheumatol; 2005 Feb; 19(1):163-77. PubMed ID: 15588977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of biological agents in the treatment of rheumatoid arthritis.
    Fan PT; Leong KH
    Ann Acad Med Singap; 2007 Feb; 36(2):128-34. PubMed ID: 17364080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis initial therapy: unanswered questions.
    O'Dell J
    J Rheumatol Suppl; 2005 Jan; 72():14-6. PubMed ID: 15660457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The meaning of biologic therapy in the treatment of rheumatoid arthritis with the focus on clinical remission. Part I. Tumor necrosis factor alpha inhibitors].
    Swierkot J; Madej M
    Pol Merkur Lekarski; 2011 Apr; 30(178):283-8. PubMed ID: 21595176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
    Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K;
    Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.
    Lenert A; Lenert P
    Clin Rheumatol; 2017 Jan; 36(1):1-8. PubMed ID: 27896522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.